Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
4
Lantheus
LNTH
5
Hutchmed (China)
HCM
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 8.13%40.18B | 21.19%12.03B | 25.75%11.04B | -9.20%8.4B | -5.34%8.72B | 9.05%37.16B | 10.13%9.92B | 9.13%8.78B | 4.47%9.25B | 12.76%9.21B |
Operating revenue | 8.13%40.18B | 21.19%12.03B | 25.75%11.04B | -9.20%8.4B | -5.34%8.72B | 9.05%37.16B | 116.83%9.92B | -29.64%8.78B | 4.47%9.25B | 12.76%9.21B |
Cost of revenue | 7.63%5.95B | -18.24%-9.01B | 22.79%5.79B | 5.69%4.66B | 12.07%4.5B | 14.34%5.52B | -25.52%-7.62B | 5.02%4.72B | 37.57%4.41B | 25.33%4.01B |
Gross profit | 8.22%34.23B | 19.91%21.03B | 29.19%5.25B | -22.78%3.73B | -18.79%4.22B | 8.18%31.63B | 16.33%17.54B | 14.31%4.07B | -14.34%4.83B | 4.65%5.19B |
Operating expense | 1.14%21.72B | 3.49%18.41B | -48.03%1.05B | 1,107.43%1.03B | -30.74%1.23B | -6.35%21.47B | 29.52%17.79B | -27.86%2.02B | -102.93%-102.71M | -38.84%1.77B |
Selling and administrative expenses | -16.79%3.98B | ---- | ---- | ---- | ---- | -18.83%4.78B | ---- | ---- | ---- | ---- |
-General and administrative expense | -16.79%3.98B | ---- | ---- | ---- | ---- | -18.83%4.78B | ---- | ---- | ---- | ---- |
Depreciation amortization depletion | 10.12%3.99B | ---- | ---- | ---- | ---- | 34.61%3.62B | ---- | ---- | ---- | ---- |
-Depreciation and amortization | 10.12%3.99B | ---- | ---- | ---- | ---- | 34.61%3.62B | ---- | ---- | ---- | ---- |
Provision for doubtful accounts | 28.21%574.79M | ---- | ---- | ---- | ---- | -91.07%448.31M | ---- | ---- | ---- | ---- |
Other taxes | -53.68%267.78M | 75.63%102.69M | -85.09%59.07M | -3.93%54.58M | -22.80%51.45M | -5.52%578.16M | -82.85%58.47M | 46.15%396.25M | --56.81M | --66.64M |
Other operating expenses | 7.19%12.91B | 9.99%9.76B | -38.96%988.73M | 714.42%980.13M | -31.05%1.18B | 38.22%12.04B | 483.51%8.87B | 105.50%1.62B | -104.55%-159.52M | -41.14%1.71B |
Operating profit | 23.19%12.52B | 1,159.14%2.62B | 105.16%4.2B | -45.35%2.7B | -12.61%2.99B | 60.97%10.16B | -118.42%-247.76M | 169.05%2.05B | 130.85%4.94B | 65.60%3.42B |
Net non-operating interest income expense | 4.68%-12.33B | -14.36%-3.34B | 11.38%-2.82B | 4.05%-2.92B | 14.26%-3.24B | -113.31%-12.93B | -21.19%-2.92B | -79.90%-3.18B | -23.26%-3.05B | -742.38%-3.78B |
Non-operating interest income | -9.64%138.67M | 243.30%21.79M | 182.99%45.17M | 447.74%39.47M | -77.85%32.23M | -84.78%153.46M | -106.58%-15.21M | -93.50%15.96M | --7.21M | --145.5M |
Non-operating interest expense | -5.35%6.12B | 22.65%1.56B | -59.79%214.24M | -6.17%2.12B | -7.31%2.23B | 37.38%6.46B | 84.79%1.27B | -75.96%532.8M | --2.26B | --2.4B |
Total other finance cost | -4.14%6.35B | 10.33%1.81B | -0.55%2.65B | 6.03%846.23M | -31.32%1.05B | 179.85%6.62B | -16.26%1.64B | 1,428.40%2.67B | -33.64%798.14M | 358.59%1.52B |
Other net income (expense) | 131.73%10.43B | 123.41%1.78B | 267.08%7B | 30.54%764.09M | -26.72%888.93M | 45.28%4.5B | 1,186.52%796.64M | 139.43%1.91B | -64.06%585.34M | 62.37%1.21B |
Gain on sale of security | -35.89%968.61M | 13.35%512.07M | -79.88%92.91M | 146.82%55.43M | -56.94%308.2M | -45.18%1.51B | -70.40%451.75M | 121.12%461.69M | ---118.39M | --715.7M |
Earnings from equity interest | 21.39%2.5B | 81.45%478.49M | 13.61%748.5M | 11.02%700.25M | 13.19%575.96M | -12.98%2.06B | -62.43%263.7M | 18.65%658.83M | 29.64%630.74M | -18.72%508.83M |
Special income (charges) | -25.45%699.76M | ---- | ---- | ---- | ---- | 137.84%938.66M | ---- | ---- | ---- | ---- |
-Less:Restructuring and merger&acquisition | --0 | ---- | ---- | ---- | ---- | ---593.13M | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | -155.81%-533.77M | ---- | ---- | ---- | ---- | 257.15%956.49M | ---- | ---- | ---- | ---- |
-Less:Other special charges | 87.14%-160.29M | ---- | ---- | ---- | ---- | -156.33%-1.25B | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | -89.77%5.7M | ---- | ---- | ---- | ---- | --55.69M | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 64,722.38%6.26B | 110.43%89.45M | 683.21%6.16B | -88.48%8.41M | 141.61%4.77M | -102.14%-9.69M | -578.57%-857.48M | 2,333.92%786.25M | -39.69%72.99M | -109.47%-11.46M |
Income before tax | 514.49%10.62B | 144.88%1.06B | 986.72%8.38B | -78.19%539.7M | -25.58%635.63M | -48.36%1.73B | -108.40%-2.37B | 462.77%771.23M | 91.09%2.47B | -74.90%854.06M |
Income tax | 108.01%240.03M | 98.53%-47.95M | 268.12%1.19B | -329.79%-1.2B | -31.91%305.1M | -531.06%-3B | -395.21%-3.26B | -231.92%-705.35M | -34.01%523.5M | -42.11%448.09M |
Net income | 136.20%10.38B | 24.50%1.11B | 387.29%7.2B | 7.65%1.74B | -18.58%330.53M | 20.79%4.39B | 286.66%893.41M | 49.65%1.48B | 222.76%1.62B | -84.56%405.96M |
Net income continuous Operations | 119.61%10.38B | 24.50%1.11B | 297.84%7.2B | 7.65%1.74B | -18.58%330.53M | 78.27%4.73B | 286.66%893.41M | 2,055,328.41%1.81B | 222.76%1.62B | -84.56%405.96M |
Net income discontinuous operations | --0 | --0 | ---- | ---- | ---- | -133.65%-332.01M | --0 | ---- | ---- | ---- |
Minority interest income | 101.70%2.63M | 221.38%4.42M | 9.15%-6.64M | 103.58%2.37M | 103.00%2.48M | -5,255.17%-154.91M | -54.24%1.38M | 34.78%-7.31M | -167.08%-66.32M | 5.70%-82.66M |
Net income attributable to the parent company | 128.10%10.38B | 24.19%1.11B | 385.34%7.2B | 3.27%1.74B | -32.86%328.05M | 25.15%4.55B | 285.21%892.03M | 48.70%1.48B | 318.46%1.69B | -82.01%488.62M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 128.10%10.38B | 24.19%1.11B | 385.34%7.2B | 3.27%1.74B | -32.86%328.05M | 25.15%4.55B | 285.21%892.03M | 48.70%1.48B | 318.46%1.69B | -82.01%488.62M |
Basic earnings per share | 130.30%4.56 | 25.64%0.49 | 389.23%3.18 | 2.74%0.75 | -33.33%0.14 | 8.79%1.98 | 286.34%0.39 | 49.89%0.65 | 298.17%0.73 | -87.87%0.21 |
Diluted earnings per share | 129.59%4.5 | 23.08%0.48 | 392.19%3.15 | 1.39%0.73 | -33.33%0.14 | 8.89%1.96 | 286.34%0.39 | 47.59%0.64 | 292.72%0.72 | -87.87%0.21 |
Dividend per share | 478.83%1.2802 | 0.8729 | 0 | 84.18%0.4074 | 0 | -70.11%0.2212 | 0 | 0 | -70.11%0.2212 | 0 |
Currency Unit | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL | BRL |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |